PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK and PD information necessary for clients’ go/no go decisions and to determine appropriate dosing ranges in Phase II studies.
You may also be interested in:
Poster
Real-World Misuse Abuse and Dependence of Abuse Deterrent
Abuse deterrent formulations of opioid medications (ADOs) may help curtail the widespread abuse, misuse, and diversion of these products.With the…
View Resource
Page
Sustainability
We’re committed to meaningfully integrating sustainability considerations into our business practices and culture. The work we do has a global…
Read More
Case Study
PRA Successfully Delivers A Complex Phase I Psoriasis Study
Exceptional Support and Innovative Strategies Combat Study Challenges.
View Resource
View all related content and resources for Clinical Pharmacology
Explore Insights